European Journal of Heart Failure
Effectiveness of Finerenone in Slowing Chronic Kidney Disease Progression After Hospitalization for Heart Failure: A FIDELITY Subgroup Analysis
Randomised trial in peopleFinerenone
Papers by Meike Brinker
15 results
- European Heart Journal
Finerenone in hypertensive non-diabetic chronic kidney disease: a FIND-CKD subgroup analysis
Trial in peopleInterventions - Journal of Cardiac Failure
The HFpEF-ABA Score, Incident Heart Failure, and Finerenone in Chronic Kidney Disease with Type 2 Diabetes
Randomised trial in 11,950 peopleFinerenone
- ADA Scientific Sessions 2026 Abstract
Inflammation, Body Mass Index, and Cardiovascular Outcomes in Chronic Kidney Disease and Type 2 Diabetes
Trial in peopleBiomarkers - ADA Scientific Sessions 2026 Abstract
Hypokalemia, Finerenone, and New-Onset Diabetes in Heart Failure
Trial in peopleInterventions - AHA Scientific Sessions 2025 Abstract
Finerenone Reduces Loop Diuretic Requirement in Patients with Type 2 Diabetes and CKD: Participant-Level Pooled Analysis of FIDELIO-DKD and FIGARO-DKD
Trial in peopleInterventions - AHA Scientific Sessions 2025 Abstract
Effects of Finerenone on Heart Failure Outcomes According to Baseline Heart Failure Risk: Insights from the FIDELITY Program
Trial in peopleInterventions - AHA Scientific Sessions 2025 Abstract
Estimated Lifetime Benefits of Finerenone on Cardiorenal Morbidity and Mortality in Patients with Type 2 Diabetes and Chronic Kidney Disease
Trial in peopleInterventions - AHA Scientific Sessions 2025 Abstract
Timing of Cardiovascular and Kidney Benefits with Finerenone in Heart Failure and Chronic Kidney Disease with Type 2 Diabetes
Trial in peopleInterventions - AHA Scientific Sessions 2025 Abstract
Interplay Between Heart Failure Progression, New-Onset Diabetes, and Finerenone: A FINEARTS-HF Analysis
Trial in peopleInterventions - AHA Scientific Sessions 2025 Abstract
Major Adverse Cardiovascular Events across the Spectrum of Cardio-Kidney-Metabolic Syndrome: A FINE-HEART Pooled Analysis
Trial in peopleInterventions - AHA Scientific Sessions 2025 Abstract
The HFpEF-ABA Algorithm and Finerenone in Chronic Kidney Disease with Type 2 Diabetes: A FINE-HEART Analysis
Trial in peopleBiomarkers - AHA Scientific Sessions 2025 Abstract
Finerenone Reduces Sudden Death across the Spectrum of Cardio-Kidney-Metabolism: the FINE-HEART Pooled Analysis
Trial in peopleInterventions - ADA Scientific Sessions 2025 Abstract
The Confidence Trial—Efficacy/Safety of Combining Finerenone with Empagliflozin in People with Chronic Kidney Disease and Type 2 Diabetes
Trial in peopleInterventions